clinicaltrialsarena10h
Real world data and patient planning can keep trials from collapsing
Speaking at the Clinical Trials in Oncology conference in Munich, GlobalData’s Ophelia Chan broke down how many real world data saves trials.
clinicaltrialsarena9h
Lilly’s Zepbound wins the weight loss duel with Novo’s Wegovy
An open-label Phase III trial showed that participants using Zepbound saw 47% greater relative weight loss compared to Wegovy.
clinicaltrialsarena12h
Vaxcyte doses first subject in pneumococcal conjugate vaccine trial in infants
Vaxcyte has commenced the Phase II trial of its 31-valent pneumococcal conjugate vaccine (PCV) candidate, VAX-31, in healthy infants.
clinicaltrialsarena14h
Patient data understanding must be a priority in trials, say expert panel
Clinical Trials in Oncology conference a panel urged trial designers to be considerate of what they are asking from patients.
clinicaltrialsarena10h
Study shows mortality impact of alcohol consumption in Mexico
GlobalData epidemiologists project that 12-month total prevalent cases of alcohol use disorder (AUD) in Mexico will rise to 2,420,000 by 2028.
clinicaltrialsarena14h
VivaVision to advance non-steroidal therapy in Phase III following Phase II win
Vivavision’s non-steroidal immunomodulator met the primary endpoint in a Phase II trial as a post-op inflammation treatment after cataract surgery.
clinicaltrialsarena16h
Medical firms urged not to let assumptions put patients at risk
Clinical Trials in Oncology conference, healthcare companies were urged to keep rigorous records during clinical trials.
clinicaltrialsarena14h
Arrowhead seeks approval to begin RNAi therapy trial for obesity treatment
Arrowhead Pharmaceuticals has sent an application to the New Zealand regulator seeking clearance to commence a Phase I/IIa trial of ARO-ALK7.